Literature DB >> 5015040

Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action.

K Fukui, H Takagi.   

Abstract

1. The administration of an analgesic dose (10 mg/kg, s.c.) of morphine increased the concentrations of the dopamine metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brains of normal mice, and the time course of the change in the DOPAC concentration corresponded approximately to that of morphine analgesia. The increase in the concentration of the DOPAC induced by morphine (20 mg/kg, s.c.) was completely suppressed by nalorphine (2 mg/kg, s.c.) given 5 min after the morphine administration.2. In morphine-tolerant mice the concentrations of DOPAC and HVA in the brain did not differ from those observed in normal mice, and the increase in the concentrations of DOPAC and HVA in brain after the acute administration of morphine no longer occurred.3. Nalorphine (2 mg/kg) given alone did not cause any change in brain DOPAC and HVA concentrations in normal mice.4. The morphine-induced increase in DOPAC and HVA concentrations in the brain are discussed in the light of the hypothesis that dopamine might participate not only in the extrapyramidal motor system but also in the sensory mechanisms of the brain.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5015040      PMCID: PMC1665695          DOI: 10.1111/j.1476-5381.1972.tb07236.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.

Authors:  R LAVERTY; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1965-06

2.  Noradrenaline and adrenaline in the rat brain during acute and chronic morphine administration and during withdrawal.

Authors:  L M GUNNE
Journal:  Nature       Date:  1959-12-19       Impact factor: 49.962

3.  Central influences on spinal afferent conduction.

Authors:  K E HAGBARTH; D I KERR
Journal:  J Neurophysiol       Date:  1954-05       Impact factor: 2.714

4.  Tolerance to morphine. I. Effects on catecholamines in the brain and adrenal glands.

Authors:  E W MAYNERT; G I KLINGMAN
Journal:  J Pharmacol Exp Ther       Date:  1962-03       Impact factor: 4.030

5.  Suppressive effect of tetrabenzine on the development of tolerance to morphine and its reversal by DOPA.

Authors:  H Takagi; H Kuriki
Journal:  Int J Neuropharmacol       Date:  1969-03

6.  Actions of L-glutamate, acetylcholine and dopamine on single neurons in the nuclei cuneatus and gracilis of the cat.

Authors:  F A Steiner; M Meyer
Journal:  Experientia       Date:  1966-01-15

7.  Relation of brain stem activity to the evoked potential in the spinal cord following the single volley of the splanchnic nerve.

Authors:  M Urabe; T Tsubokawa; H Sakurai; M Seki
Journal:  Folia Psychiatr Neurol Jpn       Date:  1965

Review 8.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

9.  Release to the cerebral ventricles of substances with possible transmitter function in the caudate nucleus.

Authors:  P J Portig; M Vogt
Journal:  J Physiol       Date:  1969-10       Impact factor: 5.182

10.  INHIBITION OF EVOKED POTENTIALS BY STRIATAL STIMULATION AND ITS BLOCKAGE BY STRYCHNINE.

Authors:  G M KRAUTHAMER
Journal:  Science       Date:  1963-11-29       Impact factor: 47.728

View more
  13 in total

1.  Response of nigral dopamine neurons to actue and prolonged morphine treatment: effect of exposure to cold, physostigmine and nicotine.

Authors:  R Lienhart; W Lichtensteiger; H Langemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 2.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

3.  Are cholinergic mechanisms involved in morphine effects on motility?

Authors:  K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  The antagonizing effect of aspartic acid on the brain levels of monoamines and free amino acids during the development of tolerance to the physical dependence on morphine.

Authors:  H Koyuncuoğlu; E Genc; M Güngör; L Eroğlu; H Sağduyu
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

5.  Tolerance to the behavioral and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol.

Authors:  S K Puri; H Lal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Effects of orotic acid on the development of morphine tolerance.

Authors:  G Grecksch; T Ott; H Matthies
Journal:  Psychopharmacologia       Date:  1974-05-15

7.  Behavioural and pharmacological studies on morphine-induced excitation of rats. Possible relation to brain catecholamines.

Authors:  I H Ayhan; A Randrup
Journal:  Psychopharmacologia       Date:  1973

8.  The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain.

Authors:  M F Sugrue
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

9.  Morphine analgesia and the bulbospinal noradrenergic system: increase in the concentration of normetanephrine in the spinal cord of the rat caused by analgesics.

Authors:  H Shiomi; H Takagi
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

10.  Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.

Authors:  S Kaakkola; L Ahtee
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.